Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04038970
What this trial is testing

Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 145
Large-scale testing (Phase 3)Study completedNCT00409838
What this trial is testing

A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 113
Testing effectiveness (Phase 2)Study completedNCT00689728
What this trial is testing

Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy

Who this might be right for
Arthritis, Rheumatoid
Eli Lilly and Company 100
Large-scale testing (Phase 3)Study completedNCT01235507
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 71
Testing effectiveness (Phase 2)Looking for participantsNCT07453095
What this trial is testing

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

Who this might be right for
Mantle Cell Lymphoma
Fondazione Italiana Linfomi - ETS 41
Large-scale testing (Phase 3)Study completedNCT00810199
What this trial is testing

Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 556
Not applicableWithdrawnNCT02786563
What this trial is testing

Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie
Testing effectiveness (Phase 2)WithdrawnNCT06646016
What this trial is testing

EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis

Who this might be right for
Immune-related Colitis
Therakos LLC
Not applicableStudy completedNCT01557348
What this trial is testing

An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,239
Large-scale testing (Phase 3)Study completedNCT03104374
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug

Who this might be right for
Psoriatic Arthritis
AbbVie 642
Post-approval studies (Phase 4)WithdrawnNCT05499416
What this trial is testing

Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis

Who this might be right for
Psoriasis VulgarisActive Psoriatic Arthritis
Innovaderm Research Inc.
Large-scale testing (Phase 3)Study completedNCT06020144
What this trial is testing

Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs

Who this might be right for
Rheumatoid Arthritis
Hangzhou Highlightll Pharmaceutical Co., Ltd 459
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07619898
What this trial is testing

PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure

Who this might be right for
ColitisHepatitisMelanoma (Skin Cancer)
Therakos LLC 112
Testing effectiveness (Phase 2)Study completedNCT00413660
What this trial is testing

Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 509
Testing effectiveness (Phase 2)Study completedNCT00292422
What this trial is testing

Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biogen 50
Post-approval studies (Phase 4)WithdrawnNCT00575302
What this trial is testing

Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age

Who this might be right for
Infertility
Centre Hospitalier Chretien 400
Post-approval studies (Phase 4)Study completedNCT05518123
What this trial is testing

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

Who this might be right for
Migraine
Pfizer 962
Large-scale testing (Phase 3)Study completedNCT00420199
What this trial is testing

A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Who this might be right for
Active Rheumatoid Arthritis
Bristol-Myers Squibb 50
Testing effectiveness (Phase 2)Study completedNCT02996500
What this trial is testing

Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate

Who this might be right for
Rheumatoid Arthritis
Pfizer 269
Large-scale testing (Phase 3)Active Not RecruitingNCT06276998
What this trial is testing

LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)

Who this might be right for
Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd 430
Next Page